Strs Ohio Anavex Life Sciences Corp. Transaction History

Strs Ohio

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$7.31 - $12.84 $38,012 - $66,768	-5,200 Reduced 54.74%	4,300 $43,000
Q3 2021 Oct 22, 2021	SELL	$16.82 - $25.75 $79,054 - $121,025	-4,700 Reduced 33.1%	9,500 $170,000
Q2 2021 Jul 26, 2021	SELL	$10.16 - $28.86 $20,320 - $57,720	-2,000 Reduced 12.35%	14,200 $324,000
Q1 2021 Apr 23, 2021	BUY	$5.17 - $16.13 $83,754 - $261,305	16,200 New	16,200 $242,000
Q4 2017 Jan 23, 2018	SELL	$3.12 - $4.94 $29,952 - $47,424	-9,600 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$3.42 - $4.87 $32,832 - $46,752	9,600	9,600 $39,000

163

27.5M

515K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $673M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.